Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tadakatsu Nakamura"'
Autor:
Tadakatsu Nakamura, Atsuhiro Kawaguchi
Publikováno v:
Clinical Pharmacology in Drug Development
Apararenone is a long‐acting, nonsteroidal mineralocorticoid receptor antagonist (MRA). The safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single‐ and multiple‐dose apararenone were assessed in 3 phase 1 ran
Publikováno v:
Clinical Therapeutics. 42:2171-2183.e4
Purpose To characterize the clinical relevance of in vitro drug–drug interaction findings with apararenone (MT-3995), the effects of apararenone on the sensitive substrates of cytochrome P450 3A4 (midazolam) and 2C9 (warfarin), and P-glycoprotein (
Autor:
Tadakatsu, Nakamura
Publikováno v:
地域政策研究 = Studies of regional policy. 17(3):15-26
Autor:
Tadakatsu, Nakamura
Publikováno v:
地域政策研究 = Studies of regional policy. 17(2):45-55
Publikováno v:
高崎経済大学論集 = The Economic Journal of Takasaki City University of Economics. 57(2):45-54
Autor:
Tadakatsu, NAKAMURA
Publikováno v:
産業研究 = Bulletin of the Institute of Regional Science. 50(1):41-52
Autor:
Tadakatsu, Nakamura
Publikováno v:
地域政策研究 = Studies of regional policy. 17(1):19-34
Publikováno v:
高崎経済大学論集 = The Economic Journal of Takasaki City University of Economics. 57(1):67-76
Autor:
Tadakatsu Nakamura, Atsushi Iwakaji, Masayoshi Imada, Tomoko Kubota, Yasunori Morio, Margit Kapás
Publikováno v:
Drug Design, Development and Therapy
Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics,
Publikováno v:
International Journal of Neuropsychopharmacology